Skip to content
Frenxiv is the French preprint archive for all scientific fields, operating on the Open Science Framework. About the archive
Frenxiv archive mark FrenxivFrench preprint archive

Preprint record

Ozonetherapy vs SARS COV 2 in gut: the fountainhead

Giovanni T. Ranaldi, Emanuele Rocco Villani, Laura Franza and Giulia Motola

Published July 22, 2020 DOI 10.31226/osf.io/e96rw Publisher Frenxiv Type Preprint

Abstract

COVID 19 is the disease caused by the new coronavirus SARS CoV 2 and is characterized by clinical manifestations ranging from mild, flu like symptoms, to severe respiratory failure and multi organ failure. Patients with more severe symptoms may require intensive care treatments and face a high risk of mortality. COVID 19 is characterized by an abnormal inflammatory response similar to a cytokine storm, which is associated with endothelial dysfunction and microvascular complications. To date, no specific treatments are available for COVID 19 and its potentially life threatening complications. Numerous experimental and clinical observations have suggested that the gut microbiota plays a key role in sepsis and ARDS pathogenesis. The incidence of diarrhea in COVID 19 patients and the high mortality rate in elderly patients, considered together, indicate a possible involvement of the intestine lung axis in COVID 19 with association of dysbiosis. Ozonetherapy is the administration of a mixture of ozone and oxygen, or Medical Ozone (MO), which produces a series of benefits capable of counteracting a wide range of pathologies, in use for over a century as an unconventional medicine practice. MO is fundamental to inhibit the activation of the inflammatory reaction and to obtain an antioxidant activity both in the tissue and in the blood. Oxidative ozone preconditioning causes an increase in SOD, GSH Px values. MO, using large auto hemo infusion or rectal insufflation technique or ozonized water, could help oxygenate the tissues better, decrease gut inflammation and regulate immune response, help slow down viral growth, regulate circulation and avoid or slow down vascular hypertrophy and consequent hyperemia , especially in the early stages, with obvious benefit at microbiome level.

Keywords

Citation

Giovanni T. Ranaldi, Emanuele Rocco Villani, Laura Franza and Giulia Motola (July 22, 2020). Ozonetherapy vs SARS COV 2 in gut: the fountainhead. Frenxiv. https://doi.org/10.31226/osf.io/e96rw

Find this record

This record is deposited on the Open Science Framework and carries a persistent DOI. Use the links below to locate it in scholarly indexes.

Open research

Open research infrastructure

Frenxiv records connect to the wider scholarly record. These services support discovery, identifiers, preservation and open licensing.